Clinical Trial Update: Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A long-term Phase 3 study evaluating the safety of dutogliptin/PHX1149T in subjects with type 2 diabetes mellitus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dutogliptin/PHX1149T (Dutogliptin)

Snippet

Sponsor: Phenomix | Conditions: Type 2 Diabetes Mellitus, Type 2 Diabetes | Phase 3 | Status: TERMINATED